Stay updated on Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.

Latest updates to the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed Revision: v3.4.1 notice about government funding and operating status.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status was added. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check28 days agoChange DetectedGlossary display was added, and metadata labels were updated to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'; the older 'Last Update Submitted that met QC Criteria', 'No FEAR Act Data', and revision note v3.3.4 were removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No other content changes were observed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section with the Texas site and updated to revision v3.3.3; removed the Texas Locations entry and the HHS Vulnerability Disclosure.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this is a minor metadata change and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib and Nivolumab in Kidney Cancer Clinical Trial page.